Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth

Autores
Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; Monteiro, Wuelton Marcelo; Barata Machado, Myrna; Fernandes da Costa, Cristiano; Yoshito Wada, Marcelo; Maximiano Faria de Almeida, Márcia Helena; Silva de Matos Fonseca, Rayanne; Mota Cordeiro, Jady Shayenne; Rodrigues Antolini, Alinne Paula; Nepomuceno, João Altecir; Fleck, Karen; Simioni Gasparotto, Fernanda; Lacerda, Marcus; Rojas Cortés, Robin; Pal, Shanthi Narayan; Porrás, Analía I.; Ade, María de la Paz; Castro, José Luis
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.
Fil: Macías Saint Gerons, Diego. Universidad de Valencia; España
Fil: Rodovalho, Sheila. Universidad Federal del Amazonas.; Brasil
Fil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; Brasil
Fil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; Brasil
Fil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; Brasil
Fil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Yoshito Wada, Marcelo. No especifíca;
Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca;
Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rodrigues Antolini, Alinne Paula. No especifíca;
Fil: Nepomuceno, João Altecir. No especifíca;
Fil: Fleck, Karen. Brazilian Health Regulatory Agency; Brasil
Fil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; Brasil
Fil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rojas Cortés, Robin. Pan American Health Organization; Estados Unidos
Fil: Pal, Shanthi Narayan. No especifíca;
Fil: Porrás, Analía I.. Pan American Health Organization; Estados Unidos
Fil: Ade, María de la Paz. Pan American Health Organization; Estados Unidos
Fil: Castro, José Luis. Pan American Health Organization; Estados Unidos
Materia
ADHERENCE
MHEALTH
PHARMACOVIGILANCE
PRIMAQUINE
SMS
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/187848

id CONICETDig_acbb1d24402382d5cc386eb2203bce55
oai_identifier_str oai:ri.conicet.gov.ar:11336/187848
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealthMacías Saint Gerons, DiegoRodovalho, SheilaBarros Dias, Ádila LilianeLacerda Ulysses de Carvalho, AndréBeratarrechea, Andrea GabrielaMonteiro, Wuelton MarceloBarata Machado, MyrnaFernandes da Costa, CristianoYoshito Wada, MarceloMaximiano Faria de Almeida, Márcia HelenaSilva de Matos Fonseca, RayanneMota Cordeiro, Jady ShayenneRodrigues Antolini, Alinne PaulaNepomuceno, João AltecirFleck, KarenSimioni Gasparotto, FernandaLacerda, MarcusRojas Cortés, RobinPal, Shanthi NarayanPorrás, Analía I.Ade, María de la PazCastro, José LuisADHERENCEMHEALTHPHARMACOVIGILANCEPRIMAQUINESMShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.Fil: Macías Saint Gerons, Diego. Universidad de Valencia; EspañaFil: Rodovalho, Sheila. Universidad Federal del Amazonas.; BrasilFil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; BrasilFil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; BrasilFil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; BrasilFil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; BrasilFil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; BrasilFil: Yoshito Wada, Marcelo. No especifíca;Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca;Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Rodrigues Antolini, Alinne Paula. No especifíca;Fil: Nepomuceno, João Altecir. No especifíca;Fil: Fleck, Karen. Brazilian Health Regulatory Agency; BrasilFil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; BrasilFil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Rojas Cortés, Robin. Pan American Health Organization; Estados UnidosFil: Pal, Shanthi Narayan. No especifíca;Fil: Porrás, Analía I.. Pan American Health Organization; Estados UnidosFil: Ade, María de la Paz. Pan American Health Organization; Estados UnidosFil: Castro, José Luis. Pan American Health Organization; Estados UnidosBioMed Central2022-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/187848Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-111475-2875CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/s12936-022-04047-3info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:05:55Zoai:ri.conicet.gov.ar:11336/187848instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:05:55.563CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
title Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
spellingShingle Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
Macías Saint Gerons, Diego
ADHERENCE
MHEALTH
PHARMACOVIGILANCE
PRIMAQUINE
SMS
title_short Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
title_full Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
title_fullStr Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
title_full_unstemmed Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
title_sort Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
dc.creator.none.fl_str_mv Macías Saint Gerons, Diego
Rodovalho, Sheila
Barros Dias, Ádila Liliane
Lacerda Ulysses de Carvalho, André
Beratarrechea, Andrea Gabriela
Monteiro, Wuelton Marcelo
Barata Machado, Myrna
Fernandes da Costa, Cristiano
Yoshito Wada, Marcelo
Maximiano Faria de Almeida, Márcia Helena
Silva de Matos Fonseca, Rayanne
Mota Cordeiro, Jady Shayenne
Rodrigues Antolini, Alinne Paula
Nepomuceno, João Altecir
Fleck, Karen
Simioni Gasparotto, Fernanda
Lacerda, Marcus
Rojas Cortés, Robin
Pal, Shanthi Narayan
Porrás, Analía I.
Ade, María de la Paz
Castro, José Luis
author Macías Saint Gerons, Diego
author_facet Macías Saint Gerons, Diego
Rodovalho, Sheila
Barros Dias, Ádila Liliane
Lacerda Ulysses de Carvalho, André
Beratarrechea, Andrea Gabriela
Monteiro, Wuelton Marcelo
Barata Machado, Myrna
Fernandes da Costa, Cristiano
Yoshito Wada, Marcelo
Maximiano Faria de Almeida, Márcia Helena
Silva de Matos Fonseca, Rayanne
Mota Cordeiro, Jady Shayenne
Rodrigues Antolini, Alinne Paula
Nepomuceno, João Altecir
Fleck, Karen
Simioni Gasparotto, Fernanda
Lacerda, Marcus
Rojas Cortés, Robin
Pal, Shanthi Narayan
Porrás, Analía I.
Ade, María de la Paz
Castro, José Luis
author_role author
author2 Rodovalho, Sheila
Barros Dias, Ádila Liliane
Lacerda Ulysses de Carvalho, André
Beratarrechea, Andrea Gabriela
Monteiro, Wuelton Marcelo
Barata Machado, Myrna
Fernandes da Costa, Cristiano
Yoshito Wada, Marcelo
Maximiano Faria de Almeida, Márcia Helena
Silva de Matos Fonseca, Rayanne
Mota Cordeiro, Jady Shayenne
Rodrigues Antolini, Alinne Paula
Nepomuceno, João Altecir
Fleck, Karen
Simioni Gasparotto, Fernanda
Lacerda, Marcus
Rojas Cortés, Robin
Pal, Shanthi Narayan
Porrás, Analía I.
Ade, María de la Paz
Castro, José Luis
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ADHERENCE
MHEALTH
PHARMACOVIGILANCE
PRIMAQUINE
SMS
topic ADHERENCE
MHEALTH
PHARMACOVIGILANCE
PRIMAQUINE
SMS
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.
Fil: Macías Saint Gerons, Diego. Universidad de Valencia; España
Fil: Rodovalho, Sheila. Universidad Federal del Amazonas.; Brasil
Fil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; Brasil
Fil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; Brasil
Fil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; Brasil
Fil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Yoshito Wada, Marcelo. No especifíca;
Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca;
Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rodrigues Antolini, Alinne Paula. No especifíca;
Fil: Nepomuceno, João Altecir. No especifíca;
Fil: Fleck, Karen. Brazilian Health Regulatory Agency; Brasil
Fil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; Brasil
Fil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rojas Cortés, Robin. Pan American Health Organization; Estados Unidos
Fil: Pal, Shanthi Narayan. No especifíca;
Fil: Porrás, Analía I.. Pan American Health Organization; Estados Unidos
Fil: Ade, María de la Paz. Pan American Health Organization; Estados Unidos
Fil: Castro, José Luis. Pan American Health Organization; Estados Unidos
description Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.
publishDate 2022
dc.date.none.fl_str_mv 2022-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/187848
Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-11
1475-2875
CONICET Digital
CONICET
url http://hdl.handle.net/11336/187848
identifier_str_mv Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-11
1475-2875
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/s12936-022-04047-3
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269934389821440
score 13.13397